癌细胞劫持生理代谢信号以播种肝脏转移
Andres R Rettig1, Karuna Ganesh1,2
1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer research
|March 19, 2024
概括
研究人员发现Pip4k2c通过增强癌细胞中的胰岛素信号传递来驱动肝转移. 这个过程可以通过特定的药物组合或性饮食来逆转,提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 代谢过程中的代谢.
背景情况:
- 转移,癌症的扩散,受到癌细胞适应和瘤微环境 (TME) 的影响.
- 了解器官特异性转移 (机体性转移) 对于开发向癌症疗法至关重要.
- 与系统生理学的TME的相互作用显著影响癌症的进展.
研究的目的:
- 为了确定肝转移的关键分子驱动因素.
- 阐明癌细胞适应特定器官环境的机制.
- 探索潜在的治疗策略,以有机变为目标.
主要方法:
- 鉴定Pip4k2c作为肝转移的一个关键因素.
- 调查Pip4k2c在调解胰岛素依赖的酸3-激酶/AKT (PI3K/AKT) 信号传递中的作用.
- 治疗干预措施的评估,包括双重PI3K/SGLT2抑制和性饮食.
主要成果:
- 确定Pip4k2c是肝转移的一个驱动因素.
- 皮普4k2c使癌细胞对胰岛素依赖的PI3K/AKT信号敏感.
- 双重抑制PI3K和SGLT2,或性饮食,逆转了转移前效应.
结论:
- 通过调节癌细胞信号传递,Pip4k2c在肝脏转移中发挥着重要作用.
- 准代谢途径和信号级联是预防或治疗肝转移的一个有希望的策略.
- 这项研究强调了系统生理学在癌症进展中的重要性,并强调了潜在的组合疗法.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K


